Yılmaz, G. Et Al. 2024. In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes. European Journal of Biology , vol.1 , 1-8.

Yılmaz, G., Çelik, S., Özel, A., & Akyüz, S., (2024). In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes. European Journal of Biology , vol.1, 1-8.

Yılmaz, Gözde Et Al. "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes," European Journal of Biology , vol.1, 1-8, 2024

Yılmaz, Gözde Et Al. "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes." European Journal of Biology , vol.1, pp.1-8, 2024

Yılmaz, G. Et Al. (2024) . "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes." European Journal of Biology , vol.1, pp.1-8.

@article{article, author={Gözde Yılmaz Et Al. }, title={In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes}, journal={European Journal of Biology}, year=2024, pages={1-8} }